TY - JOUR AU - Fine, S. L. AU - Berger, J. W. AU - Maguire, M. G. AU - Ho, A. C. PY - 2000 DA - 2000// TI - Age-related macular degeneration JO - N Engl J Med VL - 342 ID - Fine2000 ER - TY - JOUR AU - Francis, P. J. AU - Klein, M. L. PY - 2011 DA - 2011// TI - Update on the role of genetics in the onset of age-related macular degeneration JO - Clin Ophthalmol VL - 5 ID - Francis2011 ER - TY - JOUR AU - Rosenfeld, P. J. AU - Brown, D. M. AU - Heier, J. S. AU - Boyer, D. S. AU - Kaiser, P. K. AU - Chung, C. Y. PY - 2006 DA - 2006// TI - Ranibizumab for neovascular age-related macular degeneration JO - N Engl J Med VL - 355 ID - Rosenfeld2006 ER - TY - JOUR AU - Schmidt-Erfurth, U. AU - Kaiser, P. K. AU - Korobelnik, J. -. F. AU - Brown, D. M. AU - Chong, V. AU - Nguyen, Q. D. PY - 2014 DA - 2014// TI - Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies JO - Ophthalmology. VL - 121 ID - Schmidt-Erfurth2014 ER - TY - JOUR AU - Tano, Y. AU - Ohji, M. PY - 2010 DA - 2010// TI - EXTEND-I: safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration JO - Acta Ophthalmol VL - 88 ID - Tano2010 ER - TY - JOUR AU - Takahashi, K. AU - Ogura, Y. AU - Ishibashi, T. AU - Shiraga, F. AU - Yuzawa, M. PY - 2012 DA - 2012// TI - Treatment guidelines for age-related macular degeneration JO - Nihon Ganka Gakkai Zasshi VL - 116 ID - Takahashi2012 ER - TY - JOUR AU - Brown, D. M. AU - Kaiser, P. K. AU - Michels, M. AU - Soubrane, G. AU - Heier, J. S. AU - Kim, R. Y. PY - 2006 DA - 2006// TI - Ranibizumab versus verteporfin for neovascular age-related macular degeneration JO - N Engl J Med VL - 355 ID - Brown2006 ER - TY - JOUR AU - Brown, D. M. AU - Heier, J. S. AU - Ciulla, T. AU - Benz, M. AU - Abraham, P. AU - Yancopoulos, G. PY - 2011 DA - 2011// TI - Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration JO - Ophthalmology. VL - 118 ID - Brown2011 ER - TY - JOUR AU - Toalster, N. AU - Russell, M. AU - Ng, P. PY - 2013 DA - 2013// TI - A 12-month prospective trial of inject and extend regimen for ranibizumab treatment of age-related macular degeneration JO - Retina. VL - 33 ID - Toalster2013 ER - TY - JOUR AU - Sultan, M. B. AU - Zhou, D. AU - Loftus, J. AU - Dombi, T. AU - Ice, K. S. PY - 2011 DA - 2011// TI - Macugen 1013 Study Group. A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema JO - Ophthalmology VL - 118 ID - Sultan2011 ER - TY - JOUR AU - Heier, J. S. AU - Brown, D. M. AU - Chong, V. AU - Korobelnik, J. -. F. AU - Kaiser, P. K. AU - Nguyen, Q. D. PY - 2012 DA - 2012// TI - Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration JO - Ophthalmology. VL - 119 ID - Heier2012 ER - TY - JOUR AU - Rofagha, S. AU - Bhisitkul, R. B. AU - Boyer, D. S. AU - Sadda, S. R. AU - Zhang, K. PY - 2013 DA - 2013// TI - Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP) JO - Ophthalmology. VL - 120 ID - Rofagha2013 ER - TY - JOUR AU - DeCroos, F. C. AU - Reed, D. AU - Adam, M. K. AU - Salz, D. AU - Gupta, O. P. AU - Ho, A. C. PY - 2017 DA - 2017// TI - Treat-and-extend therapy using Aflibercept for Neovascular age-related macular degeneration: a prospective clinical trial JO - Am J Ophthalmol VL - 180 ID - DeCroos2017 ER - TY - JOUR AU - Ohnaka, M. AU - Nagai, Y. AU - Sho, K. AU - Miki, K. AU - Kimura, M. AU - Chihara, T. PY - 2017 DA - 2017// TI - A modified treat-and-extend regimen of aflibercept for treatment-naïve patients with neovascular age-related macular degeneration JO - Graefes Arch Clin Exp Ophthalmol VL - 255 ID - Ohnaka2017 ER - TY - JOUR AU - Ohji, M. AU - Takahashi, K. AU - Okada, A. A. AU - Kobayashi, M. AU - Matsuda, Y. AU - Terano, Y. PY - 2020 DA - 2020// TI - Efficacy and safety of Intravitreal Aflibercept treat-and-extend regimens in exudative age-related macular degeneration: 52- and 96-week findings from ALTAIR : a randomized controlled trial JO - Adv Ther VL - 37 ID - Ohji2020 ER - TY - JOUR AU - Mangione, C. M. AU - Gutierrez, P. R. AU - Lowe, G. AU - Orav, E. J. AU - Seddon, J. M. PY - 1999 DA - 1999// TI - Influence of age-related maculopathy on visual functioning and health-related quality of life JO - Am J Ophthalmol VL - 128 ID - Mangione1999 ER - TY - JOUR AU - Suzukamo, Y. AU - Oshika, T. AU - Yuzawa, M. AU - Tokuda, Y. AU - Tomidokoro, A. AU - Oki, K. PY - 2005 DA - 2005// TI - Psychometric properties of the 25-item National eye Institute visual function questionnaire (NEI VFQ-25), Japanese version JO - Health Qual Life Outcomes VL - 3 ID - Suzukamo2005 ER - TY - JOUR AU - Bressler, N. M. AU - Chang, T. S. AU - Fine, J. T. AU - Dolan, C. M. AU - Ward, J. PY - 2009 DA - 2009// TI - Anti-VEGF antibody for the treatment of predominantly classic Choroidal neovascularization in age-related macular degeneration (ANCHOR) research group. Improved vision-related function after ranibizumab vs photodynamic theraphy: a randomized clinical trial JO - Arch Ophthalmol VL - 127 ID - Bressler2009 ER - TY - JOUR AU - Chang, T. S. AU - Bressler, N. M. AU - Fine, J. T. AU - Dolan, C. M. AU - Ward, J. AU - Klesert, T. R. PY - 2007 DA - 2007// TI - Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial JO - Arch Ophthalmol VL - 125 ID - Chang2007 ER - TY - JOUR AU - Yuzawa, M. AU - Fujita, K. AU - Wittrup-Jensen, K. U. AU - Norenberg, C. AU - Zeitz, O. AU - Adachi, K. PY - 2015 DA - 2015// TI - Improvement in vision-related function with intravitreal aflibercept: data from phase 3 studies in wet age-related macular degeneration JO - Ophthalmology. VL - 122 ID - Yuzawa2015 ER - TY - JOUR AU - Gomi, F. AU - Migita, H. AU - Sakaguchi, T. AU - Okada, H. AU - Sugawara, T. AU - Hikichi, Y. PY - 2019 DA - 2019// TI - Vision-related quality of life in Japanese patients with wet age-related macular degeneration treated with intravitreal aflibercept in a real-world setting JO - Jpn J Ophthalmol VL - 63 ID - Gomi2019 ER - TY - STD TI - Bressler NM, Chang TS, Suñer IJ, Fine JT, Dolan CM, Ward J, et al. Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR. Ophthalmology. 2010;117:747–756.e4. ID - ref22 ER - TY - JOUR AU - Oshima, Y. AU - Kimoto, K. AU - Yoshida, N. AU - Fujisawa, K. AU - Sonoda, S. AU - Kubota, T. PY - 2017 DA - 2017// TI - One-year outcomes following Intravitreal Aflibercept for Polypoidal Choroidal vasculopathy in Japanese patients: the APOLLO study JO - Ophthalmologica. VL - 238 ID - Oshima2017 ER - TY - JOUR AU - Wada, I. AU - Oshima, Y. AU - Shiose, S. AU - Kano, K. AU - Nakao, S. AU - Kaizu, Y. PY - 2019 DA - 2019// TI - Five-year treatment outcomes following intravitreal ranibizumab injections for neovascular age-related macular degeneration in Japanese patients JO - Graefes Arch Clin Exp Ophthalmol VL - 257 ID - Wada2019 ER - TY - JOUR AU - Suñer, I. J. AU - Kokame, G. T. AU - Yu, E. AU - Ward, J. AU - Dolan, C. AU - Bressler, N. M. PY - 2009 DA - 2009// TI - Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials JO - Invest Ophthalmol Vis Sci VL - 50 ID - Suñer2009 ER - TY - JOUR AU - Yuzawa, M. AU - Fujita, K. AU - Tanaka, E. AU - Wang, E. C. Y. PY - 2013 DA - 2013// TI - Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice JO - Clin Ophthalmol VL - 7 ID - Yuzawa2013 ER - TY - JOUR AU - Gohil, R. AU - Crosby-Nwaobi, R. AU - Forbes, A. AU - Burton, B. J. AU - Hykin, P. AU - Sivaprasad, S. PY - 2016 DA - 2016// TI - Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting JO - Patient Prefer Adher VL - 10 ID - Gohil2016 ER - TY - JOUR AU - Wykoff, C. C. AU - Ou, W. C. AU - Brown, D. M. AU - Croft, D. E. AU - Wang, R. AU - Payne, J. F. PY - 2017 DA - 2017// TI - Randomized trial of treat-and-extend versus monthly dosing for Neovascular age-related macular degeneration: 2-year results of the TREX-AMD study JO - Ophthalmol Retina VL - 1 ID - Wykoff2017 ER - TY - JOUR AU - Ohji, M. AU - Lanzetta, P. AU - Korobelnik, J. -. F. AU - Wojciechowski, P. AU - Taieb, V. AU - Deschaseaux, C. PY - 2020 DA - 2020// TI - Efficacy and treatment burden of Intravitreal Aflibercept versus Intravitreal Ranibizumab treat-and-extend regimens at 2 years: network meta-analysis incorporating individual patient data meta-regression and matching-adjusted indirect comparison JO - Adv Ther VL - 37 ID - Ohji2020 ER - TY - JOUR AU - Gohil, R. AU - Crosby-Nwaobi, R. AU - Forbes, A. AU - Burton, B. AU - Hykin, P. AU - Sivaprasad, S. PY - 2015 DA - 2015// TI - Caregiver burden in patients receiving Ranibizumab therapy for Neovascular age related macular degeneration JO - PLoS One VL - 10 ID - Gohil2015 ER - TY - JOUR AU - Hanemoto, T. AU - Hikichi, Y. AU - Kikuchi, N. AU - Kozawa, T. PY - 2017 DA - 2017// TI - The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting JO - PLoS One VL - 12 ID - Hanemoto2017 ER - TY - JOUR AU - Joko, T. AU - Nagai, Y. AU - Mori, R. AU - Tanaka, K. AU - Oshima, Y. AU - Hikichi, Y. PY - 2020 DA - 2020// TI - Patient preferences for anti-vascular endothelial growth factor treatment for wet age-related macular degeneration in Japan: a discrete choice experiment JO - Patient Prefer Adherence VL - 14 ID - Joko2020 ER -